RB1 and metastatic neoplasm: In metastatic tumors, the frequency of homozygous deletions at RB1 was significantly higher among BRCA2d than BRCA2i tumors (17.7% versus 5.2%, padj = 0.0001) (Fig. 4b, Supplementary Table 12).